Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction - a double-blind, placebo-controlled, cross-over, multiple n = 1 study-Reference-Cited by-同舟云学术

Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction - a double-blind, placebo-controlled, cross-over, multiple n = 1 study

Published:2011-11-08 Issue:1 Volume:35 Page:48-55
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

Emmanuel A. V.,Kamm M. A.,Roy A. J.,Kerstens R.,Vandeplassche L.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2011.04907.x/fullpdf

Reference21 articles.

1. Intestinal pseudo-obstruction;Dudley;J R Coll Surg Edinb,1958

2. Chronic intestinal pseudo-obstruction in infants and children caused by diverse abnormalities of the myenteric plexus;Krishnamurthy;Gastroenterology,1993

3. Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults;Mann;Gut,1997

4. Full-thickness biopsy findings in chronic intestinal pseudo-obstruction and enteric dysmotility;Lindberg;Gut,2009

5. Functional status, health-related quality of life and symptom severity in patients with chronic intestinal pseudo-obstruction and enteric dysmotility;Iwarzon;Scand J Gastroenterol,2009

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric Chronic Intestinal Failure: Something Moving?;Nutrients;2024-09-03

2. Prokinetics‐safety and efficacy: The European Society of Neurogastroenterology and Motility/The American Neurogastroenterology and Motility Society expert review;Neurogastroenterology & Motility;2024-03-10

3. Neurogastroenterology and Motility Disorders of the Gastrointestinal Tract in Cystic Fibrosis;Current Gastroenterology Reports;2023-12-07

4. Chronic intestinal pseudo‐obstruction in adults: A practical guide to identify patient subgroups that are suitable for more specific treatments;Neurogastroenterology & Motility;2023-11-22

5. ESPEN guideline on chronic intestinal failure in adults – Update 2023;Clinical Nutrition;2023-10